Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Lyell Immunopharma, Inc. (LYEL)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
08/15/2023Klausner RichardDirectorSaleCommon Stock58k$2.28$132.3kGrantor08/15/2023
08/10/2023Lang MatthewChief Business OfficerGrantOption (right to buy)2.2M$2.31$5.2M 08/10/2023
02/24/2023Thompson RahsaanChief Legal OfficerGrantOption (right to buy)245k$2.13$521.8k 02/24/2023
02/24/2023Hill Stephen J.Chief Technical Ops. OfficerGrantOption (right to buy)900k$2.13$1.9M 02/24/2023
02/24/2023Lee Gary K.Chief Scientific OfficerGrantOption (right to buy)600k$2.13$1.3M 02/24/2023
02/24/2023Newton Charles W.CFOGrantOption (right to buy)700k$2.13$1.5M 02/24/2023
02/24/2023Albertson Tina M.Chief Medical OfficerGrantOption (right to buy)700k$2.13$1.5M 02/24/2023
12/15/2022Seely LynnPresident and CEOGrantOption (right to buy)7.5M$3.28$24.6M 12/15/2022
10/10/2022Thompson RahsaanChief Legal OfficerGrantOption (right to buy)715k$6.91$4.9M 10/10/2022
09/23/2022Klausner RichardDirectorSaleCommon Stock11.1k$6.40$71kGrantor09/23/2022
09/08/2022Bishop Hans EdgarDirectorExerciseOption (right to buy)145.4k$0.10$14.5k 09/08/2022
06/08/2022NABEL ELIZABETH GDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022BRAWLEY OTIS WDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022Bishop Hans EdgarDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022RIEFLIN WILLIAM JLDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022NELSEN ROBERT10% OwnerGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022Seely LynnPresident and CEOGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022FRIEDMAN CATHYDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2022
06/08/2022Klausner RichardDirectorGrantOption (right to buy)65k$5.31$345.2k 06/08/2021
03/16/2022Hill Stephen J.Chief Technical Ops. OfficerGrantOption (right to buy)700k$5.98$4.2M 03/16/2022
03/16/2022Newton Charles W.CFOGrantOption (right to buy)500k$5.98$3M 03/16/2022
03/16/2022Turner Heather DChief General CounselGrantOption (right to buy)300k$5.98$1.8M 03/16/2022
03/16/2022Homans ElizabethCEOGrantOption (right to buy)1.5M$5.98$8.8M 03/16/2022
02/23/2022Bishop Hans EdgarDirectorExerciseOption (right to buy)993.4k$0.10$99.3k 02/23/2022
02/11/2022Lee Gary K.Chief Scientific OfficerGrantOption (right to buy)800k$6.04$4.8M 02/11/2022
12/14/2021FRIEDMAN CATHYDirectorOther (disposition)Common Stock3.8M$0.00$0Lyell Investors, LLC12/14/2021
12/14/2021FRIEDMAN CATHYDirectorOther (acquisition)Common Stock218.7k$0.00$0MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST12/14/2021
09/13/2021Homans ElizabethCEOGrantOption (right to buy)1.4M$16.05$22M 09/13/2021
06/21/2021ARCH Venture Partners IX, LLC10% OwnerConversionCommon Stock18.2M$0.00$0ARCH Venture Fund IX, L.P.06/21/2021
06/21/2021ARCH Venture Partners IX, LLC10% OwnerConversionSeries A Convertible Preferred Stock17.8M$0.00$0ARCH Venture Fund IX, L.P.06/21/2021
06/21/2021ARCH Venture Partners IX, LLC10% OwnerConversionseries C Convertible Preferred Stock435.1k$0.00$0ARCH Venture Fund IX, L.P.06/21/2021
06/21/2021Bishop Hans EdgarDirectorConversionCommon Stock546.8k$0.00$0 06/21/2021
06/21/2021GSK plc10% OwnerConversionCommon Stock30.3M$0.00$0See Footnote06/21/2021
06/21/2021GSK plc10% OwnerConversionSeries AA Preferred Stock30.3M$0.00$0See Footnote06/21/2021
06/21/2021NELSEN ROBERT10% OwnerConversionSeries A Convertible Preferred Stock17.8M$0.00$0ARCH Venture Fund IX Overage, L.P.06/21/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy